The Functional Longevity Medicine Summit, organized by Boston BioLife from February 27 through March 1 in Phoenix, represents a concentrated effort to advance the practical application of precision medicine in aging. Unlike theoretical conferences, this working summit is designed to deliver actionable clinical and business strategies, reflecting what founder and CEO Joseph Krieger describes as a larger healthcare inflection point toward proactive, data-driven longevity strategies.
The event will focus on four critical pillars driving the field: the molecular science of aging and cellular decline, advanced functional diagnostics for clinical decisions, breakthrough therapeutic strategies for patient outcomes, and sustainable business models for longevity-focused medical practices. More than 100 medical and wellness professionals are expected to attend, seeking to navigate one of healthcare's fastest-evolving sectors.
A lineup of respected thought leaders will guide discussions, including physician and longevity expert Dr. Kien Vuu, pioneering telomere researcher Bill Andrews, performance strategist Brian Bradley, neurotechnology innovator Patrick Porter, and thyroid specialist Amie Hornaman. Exhibitors will showcase cutting-edge technologies, such as therapeutic plasma exchange programs from Lifespan Edge, alongside solutions from Life Armor, Pneuma Nitric Oxide, InHale and Integrative Peptides.
The summit has attracted media attention from outlets including NDNR.com, the Next Generation Podcast Network, the Biohacking Index, and Top Doctor Magazine. In partnership with Project One Cause, the event will support charitable initiatives benefiting Scottsdale-area communities, with involvement from former NFL player and entrepreneur AC Caswell.
For clinicians and industry professionals, this gathering underscores the accelerating convergence of business, technology, and AI in healthcare. The shift from sick care to smart care, as emphasized by Krieger, has significant implications for medical practices adapting to preventive and personalized models. The summit's focus on translating science into sustainable patient outcomes and viable business operations highlights the growing economic and clinical importance of longevity medicine.
Those interested in the summit can learn more and secure tickets through BostonBioLife.com, with a subsequent Functional Longevity Summit tentatively scheduled for June 4-7, 2026, in Washington D.C. This series of events positions Boston BioLife as a key connector in the longevity, functional medicine, and regenerative health communities, facilitating the integration of innovative solutions into mainstream healthcare practice.
